-
Internet-of-Things Security Architecture Designed
19 June 2015. Engineering students at Ruhr-Universität Bochum in Germany are developing a security architecture to protect wireless communications among small household devices connected in what’s known as the Internet-of-Things. The team from the university’s Horst Görtz Institute that specializes in IT security is also receiving funds from a German government program to start a…
-
Trial Testing Precision Medicine as Skin Cancer Therapy
18 June 2015. A clinical trial is recruiting participants to test targeted molecular therapies as treatments for advanced cases of skin cancer. The study plans to enroll 96 individuals with melanoma, an advanced and dangerous form of skin cancer, found spreading to other organs in the body and cannot be treated with surgery. Melanoma results…
-
Anti-Infection Compound Devised for Dental, Wound Care
18 June 2015. A new formulation of a common antibacterial agent can protect against infections for weeks or months at a time, according to its developers at University of Bristol in the U.K. The team led by Bristol dental materials scientist Michele Barbour is developing Pertinax, an extended antimicrobial compound, and receiving this year’s £25,000…
-
Drug Makers Start Prostate Cancer Patient Registry
17 June 2015. Two companies that developed a drug to treat prostate cancer, began enrolling individuals into a registry of people with prostate cancer to track their quality of care. Astellas U.S., a division of Astellas Pharma in Tokyo, and Medivation Inc., a biotechnology company in San Francisco, created the registry to better understand treatment…
-
Institute Developing Engineered Bacteria for Gut Diseases
17 June 2015. Engineers and medical researchers at Harvard University are designing genetically engineered bacteria that can diagnose and treat gastrointestinal disorders affecting travelers, as well as people suffering from acute or chronic gut diseases. The team from Wyss Institute for Biologically Inspired Engineering at Harvard developing the engineered microbes is funded by a $4.7…
-
Report Evaluates Industry-Academic Biotech Partner Roles
16 June 2015. A report released today by Biotechnology Industry Organization, or Bio, indicates academic research labs are playing an increasingly key role in research and development of new therapies, but it also highlights areas where partnerships between academia and industry are still evolving. Bio released the report, Advancing Translational Research for Biomedical Innovation: Measuring…
-
Patent Awarded for Early, Pre-Symptom Cancer Tests
16 June 2015. Three researchers at Kansas State University in Manhattan received a patent for an early-stage test that the inventors say can diagnose some solid tumor cancers well before symptoms develop. Kansas State chemistry professor Stefan Bossmann and anatomy-physiology professor Deryl Troyer, with postdoctoral fellow Matthew Basel, received U.S. patent number 8,969,027 in March…
-
On the Road Again
10 June 2015. Science & Enterprise is taking a break from blogging for a few days. We’ll return on Tuesday, 16 June. * * *
-
Intel Begins $125M Diversity Investment Fund
10 June 2015. The venture capital division of semiconductor manufacturer Intel unveiled a fund to invest in technology start-ups founded by women and under-represented minorities. Intel Capital announced as well the first four investments from its Capital Diversity Fund, which expects to distribute some $125 million over the next 5 years. Intel cited data showing…
-
Trial Underway Testing Immunotherapy for Gout
10 June 2015. An early-stage clinical trial is recruiting patients to test the safety of a treatment for severe gout that harnesses the immune system, but still avoids unwanted immune responses. The trial is conducted by the biotechnology company Selecta Biosciences at two sites in the U.S.: Altoona, Pennsylvania and Dallas, Texas. Gout is a…